• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Topical cyclosporine can handle more than dry-eye disease

Article

Any T-cell-mediated disease benefits from therapy without affecting other inflammatory pathways

Related Videos
Elias Kahan, MD, speaks at the 2024 ARVO meeting
Andrew Pucker, OD, PhD
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Related Content
Prior intravitreal injections may be associated with risk of postoperative cataract surgery complications

Prior intravitreal injections may be associated with risk of postoperative cataract surgery complications

Article
Claris Bio's journey toward treating neurotrophic keratitis

Claris Bio's journey toward treating neurotrophic keratitis

Podcast
Research suggests tear fluid testing as promising method for Huntington’s Disease monitoring

Research suggests tear fluid testing as promising method for Huntington’s Disease monitoring

Article
Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures

(EyePod) From idea to impact: Navigating ophthalmic innovation

Podcast
Dustin Morley, PhD, speaks at the 2024 ARVO meeting

ARVO 2024: How a deep learning model can benefit femtosecond laser-assisted cataract surgery

Article
ARVO 2024: AI may open new frontiers in vision research

ARVO 2024: AI may open new frontiers in vision research

Article
© 2024 MJH Life Sciences

All rights reserved.